Seminars in Oncology Nursing
Volume 20, Issue 1 , Pages 53-58, February 2004

Novel therapies

Abstract 

To highlight selected research directed to new drug and device technologies to manage mucositis in cancer patients and to illustrate potential impact of successful therapies.

Published research articles and abstracts, clinical experience.

Advances in molecular modeling of mucosal injury in cancer patients have created new opportunities for therapy. Research is analyzing the impact of single-agent interventions; varying degrees of efficacy are being reported. Once optimal dosing strategies for single-agent management are defined, the opportunity for multi-agent therapies will emerge.

The oncology nurse plays a pivotal role in assessing and managing mucositis in cancer patients.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 12.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0749-2081(03)00140-2

doi:10.1053/j.soncn.2003.10.009

Seminars in Oncology Nursing
Volume 20, Issue 1 , Pages 53-58, February 2004

Article Tools